Advanced Cervical Cancer (stage 3)

Description

Centered in the female pelvis, the uterine cervix is shown contiguous superiorly with the uterine corpus and inferiorly with the vaginal canal, with a bulky malignant mass expanding and distorting the ectocervix and cervical stroma. Irregular tumor margins extend laterally into the parametrium toward the pelvic sidewall, narrowing the normal fat planes that usually separate cervix from the pelvic fascia. Posteriorly, the lesion approaches the rectovaginal septum, while anterior spread brings the cervix into closer relationship with the bladder base and vesicocervical space. Surface morphology is consistent with advanced carcinoma, with ulceration, friability, and heterogeneous tumor architecture rather than a smooth, symmetric external os. Advanced disease. Stage 3 cervical cancer (FIGO III) matters because local extension, not distant metastasis, defines the immediate management problem: tumor into the lower third of the vagina, to the pelvic wall, and or obstruction of the distal ureter with hydronephrosis and loss of renal function. Lateral parametrial invasion tracks along the uterine vessels toward the internal iliac region and often coincides with pelvic lymph node involvement, which changes radiation fields and expected control rates. This is also the stage where clinical examination, pelvic MRI for stromal and parametrial invasion, and CT or PET-CT for nodal disease are commonly integrated before definitive chemoradiation, and where surgical options become limited to select situations such as post-radiation salvage. Gynecologic oncology teams can use this artwork in tumor board presentations, patient education materials on locally advanced cervical carcinoma, and in teaching files for FIGO staging and pelvic anatomy in relation to the cervix, vagina, bladder, rectum, and ureters. It also fits well in pathology and radiology coursework covering gross correlates of parametrial invasion and ureteric obstruction. Anatomical accuracy verified by SciePro's Medical Advisory Board.